Neurocrine Biosciences Inc. (NBIX)
NASDAQ · Healthcare
Neurocrine Biosciences Inc. Gross Profit 2009–2025
Neurocrine Biosciences Inc. annual/quarterly gross profit history and growth rate from 2015 to 2026. Gross profit is the profit a company makes after deducting the costs associated with making and selling its products, also known as cost of goods sold.
- Neurocrine Biosciences Inc. gross profit for the quarter ending March 31, 2026 was 800.7 M, a 42.12% increase year-over-year.
- Neurocrine Biosciences Inc. gross profit for the twelve months ending March 31, 2026 was 2.8 B, a 28.79% increase year-over-year.
- Neurocrine Biosciences Inc. annual gross profit for 2025 was 2.8 B, a 20.98% increase from 2024.
- Neurocrine Biosciences Inc. annual gross profit for 2024 was 2.3 B, a 25.65% increase from 2023.
- Neurocrine Biosciences Inc. annual gross profit for 2023 was 1.8 B, a 26.06% increase from 2022.
- Neurocrine Biosciences Inc. annual gross profit for 2022 was 1.5 B.
Gross Profit
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Neurocrine Biosciences Inc. Gross Profit — FAQ
Neurocrine Biosciences Inc. (NBIX) gross profit over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
What is Neurocrine Biosciences Inc.'s gross profit?
Neurocrine Biosciences Inc. (NBIX) reported gross profit of $2.81B for fiscal 2025.
Where can I see NBIX's gross profit history?
The chart and table above show Neurocrine Biosciences Inc.'s gross profit by year and by quarter, including the growth rate.